In type 2 diabetes, however, insulin action fails to suppress gluconeogenesis, yet it keeps activating lipogenesis, pairing two deadly weapons of metabolic syndrome: “hyperglycemia” and “hyperlipidemia”. The gene discussed is INS; the disease is type 2 diabetes mellitus.